Banner - Collaborative Care Symposium

John Berdahl, MD

Articles by John Berdahl, MD

Shan Lin, MD, and John Berdahl, MD, share their perspectives as ophthalmologists regarding the importance of comanagement.

Comanaging with the goal of better patient care

ByShan C. Lin, MD,John Berdahl, MD,Jordana Joy, Associate Editor

February 28th 2025

Shan Lin, MD, and John Berdahl, MD, share their perspectives as ophthalmologists regarding the importance of comanagement.

John Berdahl, MD, overviews the new FYXS Ocular Pressure Adjusting Pump and HERCULES trial at the Glaucoma 360 meeting.

G360 2025: The latest in glaucoma devices and pharmaceuticals

ByJohn Berdahl, MD,Sydney M Crago, Editor, Modern Retina,Jordana Joy, Associate Editor

February 21st 2025

John Berdahl, MD, overviews the new FYXS Ocular Pressure Adjusting Pump and HERCULES trial at the Glaucoma 360 meeting.

ASCRS 2023: Aurion clinical trials of endothelial cell therapy injection

ByJohn Berdahl, MD,Sydney M Crago, Editor, Modern Retina,Sheryl Stevenson, Eye Care Group Editorial Director,Martin David Harp, Editor, Ophthalmology Times

May 18th 2023

John Berdahl, MD, discussed the Aurion clinical trials of endothelial cell therapy injection at the 2023 ASCRS annual meeting in San Diego.

Look beyond IOP in treating glaucoma patients

ByBenjamin P. Casella, OD, FAAO,John Berdahl, MD

June 14th 2021

How Equinox’s new goggles might help to treat glaucoma

Latest Updated Articles

Trending on Optometry Times - Clinical News & Expert Optometrist Insights

Johnson & Johnson slated to present new contact lens data at Academy 2025

AAOpt 2025: Finding presbyopic contact lens success with Dr Erin Rueff

SightGlass to share new insights on DOT spectacle lenses during AAOpt Academy 2025

EyeCon 2025: Creating a bridge of care through toric lenses with Jade Coats, OD, FAAO

New questionnaire may be useful for assessing quality of life in patients with vision-degrading floaters

© 2025 MJH Life Sciences^®

All rights reserved.